Commerzbank Aktiengesellschaft FI Has $1.42 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

Commerzbank Aktiengesellschaft FI increased its position in shares of Colgate-Palmolive (NYSE:CL) by 130.7% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 13,665 shares of the company’s stock after purchasing an additional 7,742 shares during the period. Commerzbank Aktiengesellschaft FI’s holdings in Colgate-Palmolive were worth $1,419,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Diversify Advisory Services LLC bought a new position in Colgate-Palmolive in the 1st quarter valued at approximately $911,000. TD Asset Management Inc lifted its stake in Colgate-Palmolive by 2.4% in the 1st quarter. TD Asset Management Inc now owns 1,154,566 shares of the company’s stock valued at $103,969,000 after purchasing an additional 26,987 shares during the last quarter. Empowered Funds LLC lifted its stake in Colgate-Palmolive by 277.3% in the 1st quarter. Empowered Funds LLC now owns 33,082 shares of the company’s stock valued at $2,979,000 after purchasing an additional 24,314 shares during the last quarter. M&G Plc bought a new position in Colgate-Palmolive in the 1st quarter valued at approximately $3,812,000. Finally, Sei Investments Co. lifted its stake in Colgate-Palmolive by 41.5% in the 1st quarter. Sei Investments Co. now owns 598,639 shares of the company’s stock valued at $53,901,000 after purchasing an additional 175,445 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insiders Place Their Bets

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Panagiotis Tsourapas sold 14,794 shares of the stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the transaction, the insider now directly owns 5,146 shares of the company’s stock, valued at $529,729.24. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 43,490 shares of company stock valued at $4,486,063. Corporate insiders own 0.34% of the company’s stock.

Analysts Set New Price Targets

CL has been the topic of several analyst reports. Sanford C. Bernstein boosted their price objective on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a research note on Tuesday, July 30th. Barclays boosted their price objective on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research note on Monday, July 29th. JPMorgan Chase & Co. boosted their price objective on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Morgan Stanley boosted their price objective on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research note on Monday, July 29th. Finally, Redburn Atlantic raised shares of Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $106.00.

Colgate-Palmolive Trading Down 0.7 %

CL opened at $98.98 on Thursday. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70. Colgate-Palmolive has a fifty-two week low of $71.46 and a fifty-two week high of $109.30. The firm has a market capitalization of $81.21 billion, a PE ratio of 31.32, a P/E/G ratio of 3.54 and a beta of 0.40. The company’s 50-day moving average is $103.31 and its 200 day moving average is $97.84.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The company had revenue of $5.06 billion for the quarter, compared to analyst estimates of $5 billion. During the same quarter in the prior year, the business posted $0.77 EPS. The firm’s revenue was up 4.9% compared to the same quarter last year. As a group, research analysts predict that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.02%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s payout ratio is 63.29%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.